Congratulations to Assistant Professor Matthew LeBlanc, PhD, RN, who was selected to receive the Young Investigator Award for Exemplary Abstract at the International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
LeBlanc’s abstract, titled “Treatment access among Black and White older adults with multiple myeloma: A SEER-Medicare analysis,” represents a significant contribution to the field of myeloma research. His work sheds light on the critical issue of racial disparities in access to multiple myeloma treatment over the years, covering the period from 2007 to 2017.
The findings of LeBlanc’s research highlight a concerning trend. His study reveals that a lower percentage of Black myeloma patients initiate treatment within 12 months or receive their care from National Cancer Institute designated cancer centers compared to their White counterparts. Alarmingly, these disparities do not appear to be decreasing over time; in fact, they may be widening.
The IMS recognized the significance of LeBlanc’s research, commending his dedication to addressing disparities in multiple myeloma care. His work is a vital step toward understanding and rectifying these disparities to ensure that all patients have equal access to life-saving treatments.